Pack Design For EU Orphan Drug Launch
Source: Almac Group
Almac was engaged by a virtual, US based Pharmaceutical client seeking EU commercial product approval for their first commercial product – an ultra-orphan, solid oral dose presentation. This EU launch project required designing both the primary and secondary packaging formats (blister / wallet) and origination of country-specific artwork to comply with individual EU market requirements.
VIEW THE CASE STUDY!
Log In
Signing up provides unlimited access to:
Free Sign Up
Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Pharmaceutical Online? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP